Consistent with the above results, patients in the low-risk group also demonstrated a higher percentage of anti-tumor immune cells, including T cells, CD8+ T cells, cytotoxic T cells, B lineage, myeloid dendritic cells, and neutrophils. This evidence concerns the gene CD8A and neoplasm.